Medication

FILE - In this July 6, 2020 file photo, a health care worker administers a COVID-19 test at a site sponsored by Community Heath of South Florida at the Martin Luther King, Jr. Clinica Campesina Health Center in Homestead, Fla. A drug company says on Friday, Sept. 18, that a medicine it sells to tamp down inflammation has helped prevent the need for breathing machines in hospitalized COVID-19 patients in the first large study that primarily enrolled minorities. (AP Photo/Lynne Sladky, File)
1010 WINS Newsroom
September 18, 2020 - 10:30 am
A drug company said Friday that a medicine it sells to tamp down inflammation has helped prevent the need for breathing machines in hospitalized COVID-19 patients in the first large study that primarily enrolled Hispanics and Blacks. Switzerland-based Roche reported the results for tocilizumab,...
Read More
FILE - In this May 2020 photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. On Wednesday, Sept. 16, 2020, Lilly said that partial results from a study testing an antibody drug in mild to moderately ill COVID-19 patients give hints that the drug may help keep them from needing to be hospitalized. But the results have not been published or reviewed by independent scientists. (David Morrison/Eli Lilly via AP)
1010 WINS Newsroom
September 16, 2020 - 3:05 pm
A drug company says that partial results from a study testing an antibody drug give hints that it may help keep mild to moderately ill COVID-19 patients from needing to be hospitalized, a goal no current coronavirus medicine has been able to meet. Eli Lilly announced the results Wednesday in a...
Read More
FILE - The Eli Lilly corporate headquarters is pictured April 26, 2017, in Indianapolis. A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized COVID-19 patients shortens their time to recovery by an additional day. Eli Lilly announced the results Monday, Sept. 14, 2020, from a 1,000-person study sponsored by the U.S. National Institute of Allergy and Infectious Diseases. (AP Photo/Darron Cummings, File)
1010 WINS Newsroom
September 14, 2020 - 10:31 am
A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized COVID-19 patients shortens their time to recovery by an additional day. Eli Lilly announced the results Monday from a 1,000-person study sponsored by the U.S. National Institute of Allergy...
Read More
FILE - In this Aug. 24, 2020, file photo, Postmaster General Louis DeJoy testifies during a House Oversight and Reform Committee hearing on the Postal Service on Capitol Hill in Washington. President Donald Trump says he's open to an investigation of DeJoy after some of DeJoy's former employees said they felt pressured to donate to GOP candidates.(Tom Williams/Pool via AP)
1010 WINS Newsroom
September 09, 2020 - 2:13 pm
WASHINGTON (AP) — Delivery of mail-order prescription drugs was delayed significantly this summer after the new postmaster general ordered major changes in U.S. Postal Service operations, according to a report released Wednesday by Senate Democrats. The report contradicts public claims by Louis...
Read More
FILE - In this Aug. 23, 2020, file photo, President Donald Trump listens as Dr. Stephen Hahn, commissioner of the U.S. Food and Drug Administration, speaks during a media briefing in the James Brady Briefing Room of the White House in Washington. The credibility of two top public health agencies is on the line after controversial decisions that outside experts say suggest political pressure from the Trump administration. Hahn was forced to apologize for using an erroneous, misleading statistic describing the effectiveness of a blood plasma therapy granted emergency use for COVID-19, as Trump twisted the facts and inflated the significance of the move. (AP Photo/Alex Brandon, File)
1010 WINS Newsroom
August 28, 2020 - 8:33 pm
WASHINGTON (AP) — The credibility of two of the nation’s leading public health agencies was under fire this week after controversial decisions that outside experts said smacked of political pressure from President Donald Trump as he attempts to move past the devastating toll of the coronavirus...
Read More
FILE - In this July 31, 2020, file photo, letter carriers load mail trucks for deliveries at a U.S. Postal Service facility in McLean, Va. The success of the 2020 presidential election could come down to a most unlikely government agency: the U.S. Postal Service. (AP Photo/J. Scott Applewhite, File)
1010 WINS Newsroom
August 14, 2020 - 10:00 am
WASHINGTON (AP) — Policy changes to slow delivery at the U.S. Postal Service are taking a toll on military veterans, who are reporting much longer wait times to receive mail-order prescription drugs, according to Democratic senators. In a letter Friday, the 31 senators take aim at new Postmaster...
Read More
FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. The pandemic increased sales of Merck medicines during the first quarter of 2020, as households around the world stocked up, but the drugmaker expects a significant hit this quarter as the full force of the outbreak lands. (AP Photo/Seth Wenig, File)
1010 WINS Newsroom
July 31, 2020 - 8:12 am
FAIRLESS HILLS, PA (AP) — Surging sales of its cancer medicines and reduced spending across the board helped Merck overcome a big hit from the coronavirus pandemic and increase its profit 12% in the second quarter. The drugmaker boosted its financial forecast for the year Friday even as it spends...
Read More
FILE - In this Saturday, July 18, 2020 file photo a general view of AstraZeneca offices and the corporate logo in Cambridge, England. Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. "We are seeing good immune response in almost everybody," said Dr. Adrian Hill. Hill said Oxford has partnered with drugmaker AstraZeneca to produce their vaccine globally, and that the company has already committed to making 2 billion doses. (AP Photo/Alastair Grant, File)
1010 WINS Newsroom
July 30, 2020 - 12:27 pm
LONDON (AP) — Pharmaceutical company AstraZeneca repeated its promise not to profit from a COVID-19 vaccine during the pandemic as it reported it was on track with late-stage trials for the treatment. Such promises were boosted by strong sales across its range of treatments during lockdown. Sales...
Read More
President Donald Trump wears a face mask as he participates in a tour of Bioprocess Innovation Center at Fujifilm Diosynth Biotechnologies, Monday, July 27, 2020, in Morrisville, N.C. (AP Photo/Evan Vucci)
1010 WINS Newsroom
July 28, 2020 - 5:17 pm
WASHINGTON (AP) — The feud between conservatives and social media companies over alleged censorship escalated Tuesday after President Donald Trump and his son shared a fresh dose of misinformation about a disproven drug for treating the coronavirus in videos that were quickly taken down by Twitter...
Read More
President Donald Trump speaks during an event to sign executive orders on lowering drug prices, in the South Court Auditorium in the White House complex, Friday, July 24, 2020, in Washington. (AP Photo/Alex Brandon)
1010 WINS Newsroom
July 24, 2020 - 9:23 pm
WASHINGTON (AP) — Unable to land the big deal with Congress to curb drug costs, President Donald Trump on Friday moved on his own to allow imports of cheaper medicines, along with other limited steps that could have some election-year appeal. At a White House ceremony, Trump signed four executive...
Read More

Pages